In the News

Connect with us

Stay Informed.
Get the latest news and updates on MSK’s cancer care and research breakthroughs sent straight to your inbox with our e-newsletters.
Newsletter Sign Up
1859 News Items found
A tube of blood superimposed on a lung and a DNA helix
In the Clinic
Liquid Biopsy Is Effective at Guiding Treatment of Lung Cancer, Study Finds

The initial results of an ongoing study show that a liquid biopsy has advantages over a tissue biopsy for people with lung cancer.
MSK medical oncologist Alexander Drilon
Feature
First Targeted Cancer Drug Approved Based on Mutation Rather than Tumor Type

Learn about larotrectinib, the first cancer drug to be FDA approved for adult and pediatric patients at the same time.
Milestone Precision Medicine Decision: FDA Approves the First Treatment with an Initial Tumor-Agnostic Indication

The US Food and Drug Administration (FDA) has approved the drug larotrectinib for cancers caused by a genetic mutation called a TRK fusion. Today’s decision marks a transformation in the field of precision medicine as this is the first time that an entirely new treatment has received a tumor-agnostic indication at its initial approval, meaning that the drug was approved based on mutation type rather than on where in the body the tumor originated.
An illustration shows Helios, the ancient Greek sun god, unwinding DNA
In the Lab
Something New Under the Sun: Study in Leukemia Finds Role for Helios Protein

MSK researchers have found that a protein that contributes to one type of leukemia when it’s missing can lead to the formation of a different leukemia type when it’s present.
Male scientist speaking in front of a screen
In the News
Symposium Celebrates 15 Years of Developmental Biology at the Sloan Kettering Institute

Scientists came to give talks and celebrate the achievements that the program has made under the leadership of Kathryn Anderson.
Medical oncologist Bill Tap examines a patient
Feature
Outsmarting Sarcoma: How MSK’s Experts Are Advancing Treatment and Research Progress

Spend a day with the expert team in MSK's world-renowned sarcoma service.
Microscopic image of lymphoma cells stained purple.
In the Lab
Researchers Discover New Strategy for Foiling Drug Resistance in Aggressive Lymphoma

A two-drug combination may hold the key to overcoming resistance in an aggressive form of non-Hodgkin lymphoma.
Amy Blumfeld and her family
Feature
Survivor Reflects on Treatment and Life after Cancer — On the Page

Meet author Amy Blumenfeld, whose experience as a pediatric patient at Memorial Sloan Kettering inspired her first novel, The Cast.
3D organelle
In the Lab
This Newly Discovered Organelle Is Fierce

It’s not every day that scientists discover a new part of the cell. Two biologists from the Sloan Kettering Institute just did.
Adding Meaning to Their Miles: Fred’s Team Takes the TCS New York City Marathon

More than 50,000 runners traversed 26.2 miles across five boroughs for the TCS New York City Marathon. Among them were 925 participants who ran in support of Fred’s Team. Fred’s Team is the running program for Memorial Sloan Kettering Cancer Center (MSK), which is dedicated to moving closer to a world without cancer.